CLINICAL TRIALS PROFILE FOR ZTLIDO
✉ Email this page to a colleague
All Clinical Trials for Ztlido
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT04149938 ↗ | Comparative Pharmacokinetic Study of Lidocaine Patch 1.8% (ZTlido™) and Lidocaine Patch 5% (Lidoderm®) in Healthy Subjects | Completed | Scilex Pharmaceuticals, Inc. | Phase 1 | 2016-09-28 | The purpose of this study is to characterize the comparative single-dose pharmacokinetics (bioequivalence) of lidocaine patch 1.8% (investigational product) versus Lidoderm® (lidocaine patch 5%,reference product). |
| NCT04150536 ↗ | Pharmacokinetics and Adhesion of Lidocaine Topical System 1.8% Under Conditions of Heat and Exercise | Completed | Scilex Pharmaceuticals, Inc. | Phase 1 | 2016-01-08 | The objectives of this study are to evaluate the pharmacokinetic and adhesion performance of ZTlido (lidocaine topical system) 1.8% during physical exercise, application of heat, and under normal conditions. |
| NCT04312750 ↗ | Adhesion of Lidocaine Topical System 1.8% | Completed | Scilex Pharmaceuticals, Inc. | Phase 1 | 2015-12-01 | The objective of this study is to evaluate the adhesion performance of ZTlido (lidocaine topical system) 1.8% in normal, healthy volunteers. |
| NCT04319926 ↗ | Adhesion Performance Study of Lidocaine Topical System 1.8% Compared to Generic Lidocaine Patch 5% in Healthy, Adult, Human Subjects | Completed | Scilex Pharmaceuticals, Inc. | Phase 1 | 2018-09-07 | An open label, randomized, two-treatment, two-period, single-dose study evaluating the product adhesion in healthy, adult subjects using ZTlido 1.8% Topical System and a generic Lidocaine Patch 5% |
| NCT04320173 ↗ | Adhesion Performance Study of Lidocaine Topical System 1.8% Compared to Lidocaine Patch 5% and Lidocaine Medicated Plaster 5% in Healthy, Adult, Human Subjects | Completed | Scilex Pharmaceuticals, Inc. | Phase 1 | 2017-02-14 | The primary objective of this study was to evaluate the adhesion performance of ZTlido® (lidocaine topical system) 1.8% compared to adhesion performance for Lidoderm® (lidocaine patch 5%) and Versatis® (lidocaine medicated plaster 5%). |
| NCT04784728 ↗ | Pharmacokinetics and Adhesion of Lidocaine Topical System 1.8% With Water Exposure | Completed | Scilex Pharmaceuticals, Inc. | Phase 1 | 2019-08-21 | The objectives of this study are to evaluate the adhesion performance and pharmacokinetics of ZTlido (lidocaine topical system) 1.8% during swimming, showering, and under normal conditions. |
| NCT04819581 ↗ | Pharmacokinetic Study of SP-103 in Healthy Adult Human Subjects | Completed | Scilex Pharmaceuticals, Inc. | Phase 1 | 2019-08-03 | This study will assess the systemic exposure and pharmacokinetic parameters of SP-103 topical system following one, two, or three topical system applications and compare to the pharmacokinetics of ZTlido. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Ztlido
Condition Name
Clinical Trial Locations for Ztlido
Trials by Country
Clinical Trial Progress for Ztlido
Clinical Trial Phase
Clinical Trial Sponsors for Ztlido
Sponsor Name
